SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,003.82 -777.94
( -1.04%)

Global Indices

Nasdaq

52,102.03 -340.17
(-0.65%)

Dow Jones

7,605.54 -35.44
(-0.46%)

Hang Seng

63,634.18 141.19
(0.22%)

Nikkei 225

10,654.59 -42.98
(-0.40%)

Forex

USD-INR

95.47 0.03
(0.03%)

EUR-INR

110.72 -0.23
(-0.20%)

GBP-INR

129.12 -0.04
(-0.03%)

JPY-INR

0.62 0.00
(0.29%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Coral Laboratories Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524506

INE683E01017

585.7467787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

10.65

201.9

EPS(TTM)

Face Value()

Div & Yield %

53.11

0.35

Back

kaizen agro infrbuild ltd

Advanced Enzyme Technologies consolidated net profit declines 7.11% in the June 2026 quarter

Aug 08,2026

Net profit of Advanced Enzyme Technologies declined 7.11% to Rs 37.09 crore in the quarter ended June 2026 as against Rs 39.93 crore during the previous quarter ended June 2025. Sales rose 2.09% to Rs 189.79 crore in the quarter ended June 2026 as against Rs 185.91 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	189.79	185.91	2
OPM %	26.86	30.35	-
PBDT	63.41	64.52	-2
PBT	53.53	54.90	-2
NP	37.09	39.93	-7

74,003.82 -777.94 ( -1.04%)

52,102.03 -340.17 (-0.65%)

7,605.54 -35.44 (-0.46%)

63,634.18 141.19 (0.22%)

10,654.59 -42.98 (-0.40%)

95.47 0.03 (0.03%)

110.72 -0.23 (-0.20%)

129.12 -0.04 (-0.03%)

0.62 0.00 (0.29%)